XML 14 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Jun. 30, 2018
Dec. 31, 2017
Current assets    
Cash and cash equivalents $ 10,581,112 $ 19,857,833
Restricted cash, short-term 11,028,824 10,701,305
Accounts receivable 2,128,957 1,802,107
Inventory 2,908,249 2,983,249
Deferred costs 94,339,146 0
Prepaid expenses and other current assets 1,389,933 2,019,999
Total current assets 122,376,221 37,364,493
Property, plant and equipment, net 132,574 138,640
Restricted cash, long-term 1,701,843 6,542,448
Deferred costs 0 96,592,334
Deferred tax asset, net 2,441,740 2,431,963
Goodwill 898,334 898,334
Other assets 789,913 702,167
Total assets 128,340,625 144,670,379
Current liabilities    
Accounts payable 1,412,595 1,328,867
Accrued expenses and other current liabilities 3,288,437 4,226,261
Deferred revenue 376,562,998 1,255,318
Warrant liability 14,408,991 11,466,162
Total current liabilities 381,264,030 6,810,446
Deferred revenue 0 377,641,485
Other liabilities 704,858 840,253
Long-term debt 73,280,477 71,050,324
Total liabilities 469,658,356 467,808,670
Commitments and Contingencies
Stockholders’ deficiency    
Common stock ($.0001 par value, 600,000,000 shares authorized, 79,160,058 and 79,039,000 issued and outstanding at June 30, 2018, and December 31, 2017, respectively) 7,916 7,904
Additional paid-in capital 214,906,962 214,229,581
Accumulated deficit (556,232,609) (537,375,776)
Total stockholders’ deficiency (341,317,731) (323,138,291)
Total liabilities and stockholders’ deficiency $ 128,340,625 $ 144,670,379